PreveCeutical Medical Inc. (CSE:PREV)

Market Cap	11.96M +10.4%
Revenue (ttm)	n/a
Net Income	-3.12M
EPS	-0.01
Shares Out	598.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	214,001
Average Volume	98,748
Open	0.0250
Previous Close	0.0250
Day's Range	0.0200 - 0.0250
52-Week Range	0.0150 - 0.0600
Beta	-0.03
RSI	53.65
Earnings Date	Apr 24, 2026

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating ...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Stephen Van Deventer
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PREV